Truist lowered the firm’s price target on CVS Health to $103 from $109 and keeps a Buy rating on the shares as part of a broader research note on Healthcare Services names. The analyst cites the recent market moves and updates in multiples following commentary from both UnitedHealth (UNH) and Humana (HUM) around an uptick in utilization, reducing targets in Managed Care and bumping Hospital targets while remaining “broadly bullish” on both groups.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVS:
- Wells Fargo Sees Potential Purchase Window in Managed Care Stocks
- UNH Slide Prompts a Catastrophe for Health Insurer Stocks
- CVS Health announces 18 megawatt agreement with Constellation
- UnitedHealth slides, drags peers on warning of higher medical costs
- Agilon Health initiated with an In Line at Evercore ISI